AURA Q3'26 Earnings: EPS estimate is (0.37) USD

What happened

Aura Biosciences is set to announce its Q3 2026 results on November 5, with the exact time unspecified. The article lists an expected disclosure at 7:00 a.m. ET, estimated revenue of zero USD, and anticipated earnings per share of negative 0.37.

Confirmed

Global impact / market context

These are forecasts, not reported results, so the announcement will show whether sales and the loss per share differ from expectations. A revenue shortfall or larger loss could increase concern about the company’s ability to cover operating costs and its future need for cash.

Analyst inference

The article provides estimates but no Q3 2026 reported figures, and its historical table lists earnings per share estimates and reported results without revenue figures. Investors therefore lack a revenue comparison in this update and will need the announcement to assess performance against expectations.

Confirmed

What to watch

1. Compare reported revenue and earnings per share with the stated estimates; earnings per share means profit or loss divided across the company’s shares. Confirmed
2. The article lists 7:00 a.m. ET as the expected disclosure time but says the time is unspecified; check when the results are actually released. Confirmed
3. Look for any discussion of operating costs and cash needs; persistent losses alongside little or no revenue could imply greater reliance on available funding. Analyst inference

Evidence

• Original source link unavailable